Weiss Asset Management’s Novo Nordisk NVO Stock Holding History

Weiss Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Buy	+40,080	New	+$1.72M	0.02%	346
2018 Q4	–	Sell	-15,232	Closed	-$359K	–	479
2018 Q3	$359K	Hold	15,232	–	–	0.03%	127
2018 Q2	$351K	Hold	15,232	–	–	0.03%	126
2018 Q1	$375K	Hold	15,232	–	–	0.03%	131
2017 Q4	$409K	Buy	+15,232	New	+$387K	0.04%	140

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Weiss Asset Management's NVO Position: Q2 2026 in Review

Weiss Asset Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 40,080 shares worth $1.92M. The stake represents 0.02% of the portfolio and ranks #346 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in NVO as recently as Q3 2018.

Weiss Asset Management first reported a position in NVO in Q4 2017 and has held it in 5 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Weiss Asset Management held 40,080 shares of Novo Nordisk worth $1.92M as of Q2 2026.
Novo Nordisk was a new Weiss Asset Management position in Q2 2026.
Novo Nordisk made up 0.02% of Weiss Asset Management's portfolio in Q2 2026, its #346 holding.
Weiss Asset Management first reported a position in Novo Nordisk in Q4 2017 and has held it in 5 quarters since.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.